In various cancer types, NANOG exerts a pro-tumorigenic action associated with either cancer growth promotion, as observed in human gastric cancer cells [39], glioblastomas, and breast cancer cells [25], or enhanced invasiveness and malignancy, as observed in breast cancer and hepatic tumors [40,41]. The gene discussed is NANOG; the disease is glioblastoma.